200 related articles for article (PubMed ID: 23647130)
1. Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation.
Koh EJ; Yoon SJ; Lee SM
Br J Pharmacol; 2013 Jul; 169(6):1404-16. PubMed ID: 23647130
[TBL] [Abstract][Full Text] [Related]
2. PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model.
Linares I; Farrokhi K; Echeverri J; Kaths JM; Kollmann D; Hamar M; Urbanellis P; Ganesh S; Adeyi OA; Yip P; Selzner M; Selzner N
PLoS One; 2018; 13(4):e0195212. PubMed ID: 29617419
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Inoue H
Protein Pept Lett; 2008; 15(8):850-3. PubMed ID: 18855759
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
[TBL] [Abstract][Full Text] [Related]
5. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
[TBL] [Abstract][Full Text] [Related]
6. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Ueda S; Nakamura K; Imaizumi T; Takeuchi M; Inoue H
J Int Med Res; 2007; 35(4):482-9. PubMed ID: 17697525
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ).
Chen M; Li H; Wang G; Shen X; Zhao S; Su W
Metabolism; 2016 Apr; 65(4):441-53. PubMed ID: 26975536
[TBL] [Abstract][Full Text] [Related]
11. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo.
Lee BH; Hsu WH; Chang YY; Kuo HF; Hsu YW; Pan TM
Free Radic Biol Med; 2012 Dec; 53(11):2008-16. PubMed ID: 23022408
[TBL] [Abstract][Full Text] [Related]
12. 12/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion.
Xu YW; Sun L; Liang H; Sun GM; Cheng Y
Brain Res; 2010 Jan; 1307():149-57. PubMed ID: 19853588
[TBL] [Abstract][Full Text] [Related]
13. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
Tsukuda K; Mogi M; Iwanami J; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
Hypertension; 2009 Oct; 54(4):782-7. PubMed ID: 19635982
[TBL] [Abstract][Full Text] [Related]
14. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma.
Siddiqui AM; Cui X; Wu R; Dong W; Zhou M; Hu M; Simms HH; Wang P
Crit Care Med; 2006 Jul; 34(7):1874-82. PubMed ID: 16715036
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury.
Zeng S; Dun H; Ippagunta N; Rosario R; Zhang QY; Lefkowitch J; Yan SF; Schmidt AM; Emond JC
J Hepatol; 2009 May; 50(5):929-36. PubMed ID: 19303658
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
[TBL] [Abstract][Full Text] [Related]
17. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.
Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563
[TBL] [Abstract][Full Text] [Related]
18. Losartan modulates brain inflammation and improves mood disorders and memory impairment induced by innate immune activation: The role of PPAR-γ activation.
Salmani H; Hosseini M; Baghcheghi Y; Moradi-Marjaneh R; Mokhtari-Zaer A
Cytokine; 2020 Jan; 125():154860. PubMed ID: 31574424
[TBL] [Abstract][Full Text] [Related]
19. Sevoflurane Protects against Intestinal Ischemia-Reperfusion Injury by Activating Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-κB Pathway in Rats.
Liu C; Ding R; Huang W; Miao L; Li J; Li Y
Pharmacology; 2020; 105(3-4):231-242. PubMed ID: 31655824
[TBL] [Abstract][Full Text] [Related]
20. PPAR-γ Ameliorates Neuronal Apoptosis and Ischemic Brain Injury via Suppressing NF-κB-Driven p22phox Transcription.
Wu JS; Tsai HD; Cheung WM; Hsu CY; Lin TN
Mol Neurobiol; 2016 Aug; 53(6):3626-3645. PubMed ID: 26108185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
